1. (1) Education requirements for initial licensure. In order to satisfy the education requirement for an initial pharmaceutical representative license, applicants must complete a course of education of at least 10 hours. The education program must be approved by the department under OAR 836-200-0635 to 836-200-0670.The coursework must cover at least the following topics, and may also include any of the topics described in subsection (2)(a) of this rule:

   1. (a) The comparative clinical effectiveness of pharmaceutical products, evidence based medicine, or basic pharmacology;
   2. (b) The comparative cost effectiveness of pharmaceutical products, or pharmoeconomics; and
   3. (c) Legal and ethical issues related to promoting pharmaceutical products to healthcare professionals, or professional ethics generally.

2. (2) Education requirement for license renewal. In order to renew a pharmaceutical representative license, applicants must complete at least five hours of education. By applying for renewal, an applicant is affirming that they have completed five hours of education during the preceding 12 months. The education must be approved by the department under OAR 836-200-0635 to 836-200-0670. Education coursework under this section must be in one or more of the following subject areas:

   1. (a) General medical and pharmaceutical terminology and abbreviations;
   2. (b) Food and Drug Administration laws and regulations pertaining to drug marketing, labeling, and clinical trials;
   3. (c) The comparative cost effectiveness of pharmaceutical products;
   4. (d) Therapeutic drug classes and categories;
   5. (e) Professional ethics;
   6. (f) Properties and actions of drugs and drug delivery mechanisms;
   7. (g) Etiologies, characteristics, and therapeutics of disease states;
   8. (h) Pharmacology;
   9. (i) The anatomical and physiological effect of pharmaceuticals;
   10. (j) The comparative effectiveness of pharmaceutical products;
   11. (k) How to read and analyze peer-reviewed literature on pharmaceutical products; or
   12. (l) Safe prescribing practices to prevent abuse.

Statutory/Other Authority

ORS 731.244 & Or Laws 2021, ch 593

Statutes/Other Implemented

Or Laws 2021, ch 593

History

ID 2-2022, adopt filed 06/16/2022, effective 06/17/2022
ID 13-2021, temporary adopt filed 12/20/2021, effective 12/20/2021 through 06/17/2022